Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

The new PenCycle programme covers Novo Nordisk's FlexPen and FlexTouch devices, which are used to dispense insulin and other ... be able to recycle empty pens at around 2,500 Boots, Lloyds ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...

In 1985, Novo Nordisk pioneered production of recombinant human insulin in yeast ... we introduced the world’s first pen-shaped devices for subcutaneous injection in 1985.

In 2023, the global disposable pen injectors market is expected to be worth USD 25.5 billion. The market is expected to reach USD 54.4 billion by 2033, expanding at a 7.9% CAGR throughout the forecast ...